273 related articles for article (PubMed ID: 11765303)
1. A review of class III antiarrhythmic agents for atrial fibrillation: maintenance of normal sinus rhythm.
Tsikouris JP; Cox CD
Pharmacotherapy; 2001 Dec; 21(12):1514-29. PubMed ID: 11765303
[TBL] [Abstract][Full Text] [Related]
2. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
[TBL] [Abstract][Full Text] [Related]
3. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
McClellan KJ; Markham A
Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
[TBL] [Abstract][Full Text] [Related]
5. Dofetilide: a new class III antiarrhythmic agent.
Roukoz H; Saliba W
Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453
[TBL] [Abstract][Full Text] [Related]
6. A benefit-risk assessment of class III antiarrhythmic agents.
Elming H; Brendorp B; Pehrson S; Pedersen OD; Køber L; Torp-Petersen C
Expert Opin Drug Saf; 2004 Nov; 3(6):559-77. PubMed ID: 15500415
[TBL] [Abstract][Full Text] [Related]
7. [Atrial fibrillation in heart failure].
Costard-Jäckle A
Herz; 2002 Jun; 27(4):378-87. PubMed ID: 12187868
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic drug therapy of atrial fibrillation.
VerNooy RA; Mounsey JP
Cardiol Clin; 2004 Feb; 22(1):21-34. PubMed ID: 14994845
[TBL] [Abstract][Full Text] [Related]
9. Drug choices in the treatment of atrial fibrillation.
Reiffel JA
Am J Cardiol; 2000 May; 85(10A):12D-19D. PubMed ID: 10822036
[TBL] [Abstract][Full Text] [Related]
10. Potentially significant drug interactions of class III antiarrhythmic drugs.
Yamreudeewong W; DeBisschop M; Martin LG; Lower DL
Drug Saf; 2003; 26(6):421-38. PubMed ID: 12688833
[TBL] [Abstract][Full Text] [Related]
11. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.
AFFIRM First Antiarrhythmic Drug Substudy Investigators
J Am Coll Cardiol; 2003 Jul; 42(1):20-9. PubMed ID: 12849654
[TBL] [Abstract][Full Text] [Related]
12. Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation.
Torp-Pedersen C; Brendorp B; Køber L
Expert Opin Investig Drugs; 2000 Nov; 9(11):2695-704. PubMed ID: 11060831
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.
Singh BN; Mody FV; Lopez B; Sarma JS
Am J Cardiol; 1999 Nov; 84(9A):161R-173R. PubMed ID: 10568677
[TBL] [Abstract][Full Text] [Related]
14. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effect of the Ca
Kirchhoff JE; Diness JG; Abildgaard L; Sheykhzade M; Grunnet M; Jespersen T
Pflugers Arch; 2016 Nov; 468(11-12):1853-1863. PubMed ID: 27722784
[TBL] [Abstract][Full Text] [Related]
16. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM;
Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
[TBL] [Abstract][Full Text] [Related]
17. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group.
Torp-Pedersen C; Møller M; Bloch-Thomsen PE; Køber L; Sandøe E; Egstrup K; Agner E; Carlsen J; Videbaek J; Marchant B; Camm AJ
N Engl J Med; 1999 Sep; 341(12):857-65. PubMed ID: 10486417
[TBL] [Abstract][Full Text] [Related]
18. Observations on the safety and effectiveness of dofetilide in patients with paroxysmal atrial fibrillation and normal left ventricular function.
Mykytsey A; Bauman JL; Razminia M; Zheutlin T; Wang T; Saleem M; Leal S; Kehoe RF
J Cardiovasc Pharmacol Ther; 2007 Mar; 12(1):36-43. PubMed ID: 17495256
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of antiarrhythmic compounds: intrinsic effects and autonomic modulation.
Hoffmeister HM; Beyer ME; Seipel L
Am J Cardiol; 1997 Oct; 80(8A):24G-30G. PubMed ID: 9354409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
